Your browser is no longer supported. Please, upgrade your browser.
SANA [NASD]
Sana Biotechnology, Inc.
Index- P/E- EPS (ttm)- Insider Own0.50% Shs Outstand179.90M Perf Week0.85%
Market Cap4.67B Forward P/E- EPS next Y-2.13 Insider Trans-13.13% Shs Float164.80M Perf Month20.21%
Income- PEG- EPS next Q-0.49 Inst Own74.60% Short Float3.94% Perf Quarter11.02%
Sales- P/S- EPS this Y-118.20% Inst Trans4.35% Short Ratio9.09 Perf Half Y-22.45%
Book/sh5.04 P/B4.96 EPS next Y-37.40% ROA- Target Price37.50 Perf Year-
Cash/sh4.56 P/C5.47 EPS next 5Y- ROE- 52W Range16.09 - 44.60 Perf YTD-28.83%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-43.99% Beta-
Dividend %- Quick Ratio20.10 Sales past 5Y- Gross Margin- 52W Low55.25% ATR1.58
Employees321 Current Ratio20.10 Sales Q/Q- Oper. Margin- RSI (14)60.60 Volatility7.22% 7.11%
OptionableYes Debt/Eq0.00 EPS Q/Q140.20% Profit Margin- Rel Volume18.60 Prev Close25.71
ShortableYes LT Debt/Eq0.00 Earnings- Payout- Avg Volume713.95K Price24.98
Recom2.20 SMA204.41% SMA5020.19% SMA2002.19% Volume13,280,738 Change-2.84%
Mar-01-21Initiated Morgan Stanley Overweight $40
Mar-01-21Initiated JP Morgan Neutral $35
Mar-01-21Initiated Goldman Neutral $40
Mar-01-21Initiated BofA Securities Buy $45
Sep-13-21 11:20AM  
Sep-07-21 04:05PM  
Sep-02-21 01:13PM  
Aug-09-21 02:00AM  
Aug-04-21 04:05PM  
Jul-14-21 04:10PM  
Jun-26-21 10:42AM  
Jun-14-21 07:51PM  
09:15AM  
Jun-02-21 04:05PM  
May-25-21 06:00AM  
May-19-21 09:01AM  
May-05-21 04:05PM  
May-04-21 04:05PM  
06:11AM  
Apr-27-21 04:35PM  
Apr-09-21 09:00AM  
Mar-30-21 09:30AM  
Mar-24-21 04:10PM  
Mar-17-21 09:00AM  
Feb-08-21 05:24PM  
Feb-03-21 11:22PM  
Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines. The company develops in vivo and ex vivo cell engineering platforms for various therapeutic areas with unmet treatment needs, including oncology, diabetes, central nervous system disorders, cardiovascular diseases, genetic disorders, and others. Its product candidates include SG295 and SG242 that target CD19+ cancer cells, including non-Hodgkin Lymphoma, chronic lymphocytic leukemia, and acute lymphoblastic leukemia; SG221 and SG239 for the treatment of multiple myeloma; and SG328 for ornithine transcarbamylase deficiency. It also develops SG418 for sickle cell disease and beta-thalassemia; SC291, a CD19 allogeneic T cell therapy; SC255 for multiple myeloma; SC451 for type I diabetes mellitus; SC379 for secondary progressive multiple sclerosis, Pelizaeus-Merzbacher disease, and Huntington's disease; and SC187 for heart failures. Sana Biotechnology, Inc. was formerly known as FD Therapeutics, Inc. and changed its name to Sana Biotechnology, Inc. in September 2018. The company was incorporated in 2018 and is headquartered in Seattle, Washington.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
AGARWAL SUNILEVP, Head of Development & CMOSep 16Sale26.001,62742,3021,550,000Sep 17 04:27 PM
AGARWAL SUNILEVP, Head of Development & CMOSep 15Sale26.0758,3731,521,7551,551,627Sep 17 04:27 PM
Hordo ChristianEVP, Chief Business OfficerSep 10Sale25.001,47736,925942,455Sep 14 04:05 PM
Hordo ChristianEVP, Chief Business OfficerSep 09Option Exercise1.4839,20558,0231,008,603Sep 10 07:27 PM
Hordo ChristianEVP, Chief Business OfficerSep 09Sale25.0164,6711,617,491943,932Sep 10 07:27 PM
Hordo ChristianEVP, Chief Business OfficerSep 03Option Exercise1.487001,036970,098Sep 07 07:29 PM
Hordo ChristianEVP, Chief Business OfficerSep 03Sale25.0070017,500969,398Sep 07 07:29 PM
Hordo ChristianEVP, Chief Business OfficerSep 02Option Exercise1.486,5589,706977,356Sep 07 07:29 PM
Hordo ChristianEVP, Chief Business OfficerSep 02Sale25.007,958198,968969,398Sep 07 07:29 PM
Hordo ChristianEVP, Chief Business OfficerSep 01Option Exercise1.481,1341,678974,934Sep 03 04:12 PM
Hordo ChristianEVP, Chief Business OfficerSep 01Sale25.014,136103,421970,798Sep 03 04:12 PM
Hordo ChristianEVP, Chief Business OfficerAug 30Option Exercise1.481,1001,628976,100Sep 01 04:20 PM
Hordo ChristianEVP, Chief Business OfficerAug 30Sale25.012,30057,533973,800Sep 01 04:20 PM